In this journal scan, we provide a brief overview of the late-breaking trials presented at the American College of Cardiology (ACC) Conference held in Atlanta, Georgia, from April 6 to 8, 2024, and their relevance to our daily clinical practice. The trials are categorized under the following headings: A. Coronary Artery Disease (Ultimate DAPT, DanGer Shock, Reduce AMI, EMPACT-MI, ORBITA-COSMIC 2) B. Intravascular Imaging (Prevent trial, IVUS-DCB) C. Heart Failure (Relieve HF, Arise HF, Improve HCM, PROACT) D. Hypertension (Target BP1, KARDIA, Feel) E.
No takes yet. Share an insight, caveat, or question.
Nagula et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: